Medtronic plc. (MDT)
| Market Cap | 157.23B |
| Revenue (ttm) | 27.87B |
| Net Income (ttm) | 3.54B |
| Shares Out | 1.34B |
| EPS (ttm) | 2.74 |
| PE Ratio | 42.63 |
| Forward PE | 20.58 |
| Dividend | $2.32 |
| Dividend Yield | 1.99% |
| Trading Day | January 15 |
| Last Price | $116.81 |
| Previous Close | $116.81 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 117.60 |
| Day's Range | 116.59 - 118.30 |
| Day's Volume | 5,659,503 |
| 52-Week Range | 71.23 - 119.71 |
ADAPT-PD Global Study Designed to Demonstrate Safety & Efficacy of Automated Therapy Which Responds to Brain Signals in Parkinson's Disease Patients DUBLIN, Jan. 14, 2021 /PRNewswire/ -- Medtr...
Medtronic CEO says edge computing is helping to personalize medicine
Medtronic CEO Geoff Martha explained how new technologies are helping to improve therapies for treating neurodegenerative diseases, like Parkinson's disease.
Medtronic plc (MDT) CEO Geoff Martha Presents at 39th Annual JPMorgan Healthcare Conference (Transcript)
They didn't all struggle in 2020, but they will definitely all thrive if the economy bounces back this year.
Investors continue to be optimistic about Medtronic (MDT) on slew of product launches and regulatory approvals.
DUBLIN, Jan. 4, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the 39th Annual J.P. Morgan Healthcare ...
I analyzed lately both Abbott Laboratories and Owens & Minor. While Abbott is a dividend aristocrat, Owens & Minor is a speculative buy.
Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Intuitive Surgical and Medtronic are involved in robotic-assisted surgery (RAS) systems, but Intuitive's shares have soared compared to the gains enjoyed by Medtronic's stock.
The shares of Medtronic PLC (NYSE:MDT) are up 0.3% at $114.74 at last check, after J.P.
With the approval, Medtronic (MDT) aims to strengthen its Cardiac and Vascular Group business globally.
We think that 3M currently is a better pick compared to Medtronic. 3M trades at about 3.1x trailing Revenues, compared to over 5.4x for Medtronic, though both belong to different industry groups.
Medtronic's (MDT) OsteoCool RFA System is expected to provide better relief from debilitating pain for cancer patients.
Medtronic PLC (NYSE: MDT) is well-positioned for a COVID-19 recovery and has upside to the consensus estimates for fiscal 2022, according to Morgan Stanley. The Medtronic Analyst: David Lewis ...
With 2020 rapidly and thankfully coming to a close, many investors are evaluating portfolios for 2021.
DUBLIN, Dec. 15, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) Syst...
DUBLIN, Dec. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that Sean Salmon, Executive Vice President and President, Diabetes Operating Unit has been named Executive Vice P...
Medtronic plc (MDT) 2020 Annual Meeting Conference (Transcript)
Medtronic's (MDT) Carpediem CRRT system compares favorably with the traditional three times a week therapy session.
Last month, the stock market responded positively to the news of a potential Covid-19 vaccine. While the initial impact of the news appears to be dissipating, now may be the right time to look...
This article is part of our monthly series where we highlight five companies that are large cap, relatively safe, dividend paying, and are offering large discounts to their historical norms. I...
Glenview Capital Management recently disclosed its portfolio updates for the third quarter of 2020, which ended on Sept. 30.
Medtronic's (MDT) Management Presents at Piper Sandler 32nd Annual Virtual Healthcare Conference (Transcript)
DUBLIN, Dec. 1, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Evercore ISI 3rd Annual HealthCONx ...
Among several domains within the MedTech space, several pediatric medical device stocks have been gaining traction amid the coronavirus pandemic
We believe that Medtronic stock is a good buying opportunity at the present time. MDT stock trades near $115 currently and it is, in fact, down 6% from its pre-Covid high of $121 in February 2...
DUBLIN, Nov. 30, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Piper Sandler 32nd Annual Healthca...
DUBLIN and MINNEAPOLIS, Nov. 30, 2020 /PRNewswire/ -- With the pandemic surging across the globe and food insecurity on the rise, Medtronic and the Medtronic Foundation today announced an addi...
Based on the ongoing strong recovery in sales, Medtronic (MDT) expects fiscal third-quarter MITG growth to be in the low single digits.
The S&P 500 saw its trailing 12-month real earnings per share (EPS) grow by approximately 1.4% on average every year over the past five years. The index's share price ($3,629.65 as of Wednesda...
Medtronic CEO on Second Quarter, New Therapies, Covid Impact
Nov.24 -- Medtronic Chief Executive Officer Geoff Martha discusses second-quarter results, new products and therapies, and efforts to return patients to the healthcare system amid the Covid-19...
Medtronic PLC's (MDT) CEO Geoffrey Martha on Q2 2021 Results - Earnings Call Transcript
Deferred procedures due to the pandemic impact Medtronic's (MDT) Q2 performance.
Medtronic CEO Geoff Martha on earnings and how Covid is impacting business
Medtronic released its quarterly earning results that exceeded what analysts had been expecting. Ventilator sales were strong, but profits fell on weaker demand for medical devices as elective...
Shares of Medtronic (NYSE:MDT) rose 0.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 22.14% over the past year to $1.02, which b...
Medtronic (MDT) delivered earnings and revenue surprises of 30.77% and 8.51%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?
Medtronic earnings and sales beat fiscal Q2 estimates. Shares of the medical products giant rose slightly, near a prior buy point.
- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ -- Medtronic plc (NYSE...
Medtronic is scheduled to report its fiscal Q2 2021 results on Tuesday, November 24. We expect Medtronic to likely beat the revenue and earnings expectations, driven by improved demand for med...
Medtronic (MDT) is hopeful about a sequential improvement of about 8% in the fiscal second quarter, which implies a 9% year-over-year decline.
Biotech stocks simply can't match these reliable returns.
Medtronic (MDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medtronic (MDT) expects Medicrea's capabilities and solutions to complement its fully-integrated procedural solution for surgical planning and delivery.
DUBLIN, Nov. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clini...
DUBLIN, Nov. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has completed its friendly tender offer for France-based Medicr...
This device maker is riding the rising tide of continuous glucose monitoring systems.
DUBLIN, Nov. 13, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced that it has been recognized as one of the world's leading companies fo...
Medtronic's (MDT) strategic acquisition of Companion Medical strengthens the company's data science and AI capabilities.
Medtronic is a Dividend Champion with 43 consecutive years of dividend growth. Shares currently yield 2.24%. Medtronic is a leader in the med-tech space with over 70 years of expertise in pus...
About MDT
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX... [Read more...]
| Industry Medical Devices | Founded 1949 |
| CEO Geoffrey Martha | Employees 90,000 |
| Stock Exchange NYSE | Ticker Symbol MDT |
Financial Performance
In 2020, Medtronic's revenue was $28.91 billion, a decrease of -5.38% compared to the previous year's $30.56 billion. Earnings were $4.79 billion, an increase of 3.41%.
Analyst Forecasts
According to 27 analysts, the average rating for Medtronic stock is "Buy." The 12-month stock price forecast is 129.29, which is an increase of 10.68% from the latest price.